Benitec Biopharma Ltd
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | 100.0% | – | – | – | – | 100.0% | – | – | – | – | – | |
| 19.8% | 69.6% | 76.7% | -23.5% | 27.0% | 47.1% | 157.0% | 21.9% | 3.4% | 3.4% | 5.4% | 4.7% | 78.8% | -397.4% | 167.9% | – | 243.6% | -1,900.0% | 700.0% | 50.0% | 4,995.1% | 0.0% | 0.0% | 36.0% | 21.6% | 292.9% | 59.3% | 1,200.0% | – | – | -50.0% | – | – | – | – | 50.0% | – | – | – | – | – | |
| 80.2% | 30.4% | 23.3% | 123.5% | 73.0% | 52.9% | -57.0% | -1.1% | 96.6% | 96.6% | 94.6% | 95.3% | 21.2% | 497.4% | -67.9% | – | -143.6% | 2,000.0% | -600.0% | 50.0% | -4,995.1% | 100.0% | 100.0% | -36.0% | -21.6% | 100.0% | 100.0% | 100.0% | – | – | 50.0% | – | – | – | – | 50.0% | – | – | – | – | – | |
| 2,267.6% | 949.4% | 634.1% | 1,580.4% | 1,115.9% | 642.5% | 1,185.6% | 85.2% | 10.8% | 2.4% | 207.0% | 196.4% | 1,281.8% | 777.9% | 2,875.0% | – | 1,407.3% | 116,800.0% | 275,800.0% | 116,000.0% | 136,141.0% | 12,584.0% | 4,522.9% | 12,704.0% | 563.6% | 26,864.3% | 5,864.8% | 45,514.3% | – | – | 42,766.7% | – | – | – | – | 664.6% | – | – | – | – | – | |
| 1,974.8% | 1,726.4% | 1,035.9% | 2,065.8% | 1,738.9% | 719.3% | 1,659.6% | 91.0% | 10.9% | 36.2% | 174.5% | 123.5% | 2,272.8% | 2,461.1% | 4,596.4% | – | 3,340.0% | 211,100.0% | 102,900.0% | 76,800.0% | 100,000.0% | 6,856.0% | 2,785.4% | 6,212.0% | 406.8% | 13,307.1% | 2,274.1% | 19,585.7% | – | – | 26,300.0% | – | – | – | – | 2,424.6% | – | – | – | – | – | |
| 5,623.7% | 4,009.6% | 1,929.4% | 4,709.4% | 3,668.3% | 1,762.3% | -57.0% | 934.8% | 42.6% | -7.2% | 403.2% | 330.3% | 3,554.6% | 3,239.0% | 7,471.4% | – | 4,747.3% | 327,900.0% | 378,700.0% | 192,800.0% | 236,141.0% | 19,440.0% | 7,308.3% | 18,916.0% | 970.3% | 40,171.4% | 8,138.9% | 65,100.0% | – | – | 69,066.7% | – | – | – | – | 3,089.2% | – | – | – | – | – | |
| -5,543.5% | -3,979.2% | -1,906.1% | -4,585.9% | -3,595.2% | -1,709.5% | -2,743.2% | -182.9% | 54.0% | 52.6% | -309.3% | -234.8% | -3,533.4% | -2,741.6% | -7,539.3% | – | -4,890.9% | -325,900.0% | -379,300.0% | -192,750.0% | -236,141.0% | -19,340.0% | -7,208.3% | -18,952.0% | -970.3% | -40,071.4% | -8,038.9% | -65,000.0% | – | – | -69,016.7% | – | – | – | – | -3,089.2% | – | – | – | – | – | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 36.7% | 15.5% | 34.7% | – | 1.8% | 200.0% | 200.0% | 50.0% | 49.0% | 44.0% | 20.8% | 40.0% | 1.9% | 64.3% | 13.0% | 114.3% | – | – | 66.7% | – | – | – | – | 186.3% | – | – | – | – | – | |
| 668.5% | -2,667.0% | -137.7% | -2,460.9% | -2,283.4% | -997.5% | -2,744.1% | -169.8% | 59.4% | 46.1% | -304.3% | -228.5% | -3,475.8% | -2,714.3% | -7,507.2% | – | -4,941.8% | -325,200.0% | -390,900.0% | -200,150.0% | -247,061.7% | -19,284.0% | -6,822.9% | -20,268.0% | -1,079.0% | -38,650.0% | -8,142.6% | -66,585.7% | – | – | -71,316.7% | – | – | – | – | -2,904.1% | – | – | – | – | – | |
| 271.8% | 2.7% | -0.8% | 140.1% | 74.8% | 50.9% | 0.9% | -13.0% | 0.0% | 0.0% | -19.8% | 0.0% | -36.7% | -15.5% | -34.7% | – | 100.0% | 300.0% | 11,600.0% | 7,400.0% | 10,920.7% | 44.0% | -385.4% | -160.0% | 108.7% | -1,421.4% | 116.7% | -1,028.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 872.9% | -5,934.6% | -136.9% | -6,308.9% | -3,703.9% | -1,693.6% | -2,744.1% | -266.0% | 59.4% | 46.1% | -304.3% | -228.5% | -3,475.8% | -2,714.3% | -7,507.2% | – | -4,941.8% | -325,200.0% | -390,900.0% | -200,150.0% | -247,061.7% | -19,284.0% | -6,822.9% | -20,268.0% | -1,079.0% | -38,650.0% | -8,142.6% | -66,585.7% | – | – | -71,316.7% | – | – | – | – | -2,904.1% | – | – | – | – | – | |
| 942.4% | -2,883.4% | -9.8% | -2,301.7% | -2,185.0% | -940.9% | -2,073.4% | -132.5% | 54.0% | 53.1% | -302.9% | -226.9% | -3,239.4% | -2,675.3% | -7,200.0% | – | -4,723.6% | -313,500.0% | -379,200.0% | -187,650.0% | -242,017.6% | -18,788.0% | -6,564.6% | -19,976.0% | -1,055.5% | -37,857.1% | -7,957.4% | -65,271.4% | – | – | -67,516.7% | – | – | – | – | -3,068.0% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.